Flow cytometric monitoring of the in vitro inhibition of the phosphorylation of CRKL and of SRC family kinases in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors
International journal of laboratory hematology.
2015 Feb ;
37 (1) :
e11-5.
[epub] 20140521
Language English Country England, Great Britain Media print-electronic
Document type Letter, Research Support, Non-U.S. Gov't
Persistent link
https://www.medvik.cz/link/pmid24845482
PubMed
24845482
DOI
10.1111/ijlh.12258
Knihovny.cz E-resources
- MeSH
- Adaptor Proteins, Signal Transducing antagonists & inhibitors MeSH
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy metabolism MeSH
- Phosphorylation drug effects MeSH
- Protein Kinase Inhibitors pharmacology therapeutic use MeSH
- Nuclear Proteins antagonists & inhibitors MeSH
- Humans MeSH
- Antineoplastic Agents pharmacology therapeutic use MeSH
- Flow Cytometry MeSH
- src-Family Kinases antagonists & inhibitors MeSH
- In Vitro Techniques MeSH
- Check Tag
- Humans MeSH
- Publication type
- Letter MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Adaptor Proteins, Signal Transducing MeSH
- CRKL protein MeSH Browser
- Protein Kinase Inhibitors MeSH
- Nuclear Proteins MeSH
- Antineoplastic Agents MeSH
- src-Family Kinases MeSH
References provided by Crossref.org
